Cited 0 times in
A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.